Dependence and withdrawal associated with some prescribed medicines: an evidence review – Public Health England

Public Health England containing the results of a public health evidence review of available data and published evidence on the problems of dependence and withdrawal associated with some prescribed medicines. It points to issues of GP prescribing and highlights how patients

More harm than good: why more isn’t always better with older people’s medicines – Age UK

Age UK report that calls for a more considered approach to prescribing medicines for our older population. It says too many older people in our society are on too many prescribed medicines, putting them at risk of side effects that

PSNC Briefing 031/19: Guidance on the seasonal influenza vaccination advanced service 2019/20 – Pharmaceutical Services Negotiating Committee

This briefing provides guidance for community pharmacy contractors and their teams on the 2019/2020 NHS seasonal influenza vaccination advanced service. It discusses the background to and aims of the service, service provision, which vaccines should be covered and training of

HSC (2008) 001 Updated national guidance on the safe administration of intrathecal chemotherapy – Department of Health

This circular covers the updated National Guidance on the Safe Administration of Intrathecal Chemotherapy. This updated guidance replaces HSC 2003/010. It sets out the minimum that should be expected of an NHS Trust providing an intrathecal chemotherapy service. It also

Guidance on the use of cannabis‐based products for medicinal use in children and young people with epilepsy – British Paediatric Neurology Association

Interim clinical guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The BPNA has been asked to highlight the key questions specialist clinicians should address before considering prescribing

Information on the community pharmacy contract settlement and funding for 2019/2020 to 2023/24 – Pharmaceutical Services Negotiating Committee

Pharmaceutical Services Negotiating Committee funding and statistics briefing that sets out the main elements of the five-year community pharmacy funding settlement for 2019/20 to 2023/24 and gives background information on what the announcement means and how community pharmacy funding works.

The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan – Department of Health and Social Care

The new contractual arrangements will come into force from 1 October 2019 and will help to deliver the ambitions set out in the NHS Long Term Plan.  It presents a 5-year deal setting out how community pharmacy will support delivery of

A short summary of The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan – NHS England and NHS Improvement

The document is a summary of changes to the community pharmacy contractual framework for 2019/20 to 2023/24, which was published jointly by the Department of Health and Social Care, the Pharmaceutical Services Negotiating Committee (PSNC).

Community pharmacy contractual framework: Letter from Ed Waller – NHS England and NHS Improvement

Letter from from Ed Waller to the Directors of Commissioning, Regional Heads of Primary Care, Heads of Primary Care, CCG Clinical Leads and Accountable Officers about the community pharmacy contractual framework.

PSNC Briefing 024/19: NHS Long Term Plan Implementation Framework – Pharmaceutical Services Negotiating Committee

This briefing summarises the elements of the NHS long term plan implementation framework that are of most relevance to community pharmacy contractors and local pharmaceutical committees.

Drugs policy: medicinal cannabis: Sixteenth Report of Session 2017–19: Report, together with formal minutes relating to the report – House of Commons Health and Social Care Committee

Report from the House of Commons Health and Social Care Committee that finds despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence

Equality and Health Inequalities: Full Analysis: Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for CCGs – NHS England

This is the equality impact assessment for the consultation ‘Items which should not routinely be prescribed in primary care – a consultation on guidance for CCGs’ which ran between 21 July and 21 October 2017.  

Report of findings: Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for CCGs

‘Items which should not routinely be prescribed in primary care – a consultation on guidance for CCGs’  ran between 21 July and 21 October 2017 – these are the results to this consultation.

Brexit letter to suppliers of medicines and medical products – Department of Health and Social Care

A letter to suppliers giving an update on ensuring a continued supply of medicines and medical products if the UK leaves the EU with no deal. The letter sets out: how the government plans to ensure a continued supply of

A new ambition for crosssector collaboration with the life sciences industry to support NHS sustainability and transformation – NHS Confederation

The NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes. In part that is because it is a monopoly purchaser but also because the NHS should be where innovative products are developed

The Human Medicines (Amendment etc.) (EU Exit) (No. 2) and the Medical Devices (Amendment etc.) (EU Exit) (No. 2) Regulations 2019 – Department of Health and Social Care

These Regulations (which come into force immediately before exit day) are made to correct drafting defects and omissions in the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775) and the Medical Devices (Amendment etc.) (EU Exit) Regulations 2019

Regulation 28: Report to prevent future deaths: Terence Bradfield – Courts and Tribunal Judiciary

Date of report: 11 March 2019 Ref: 2019-0086 Deceased name: Terence Bradfield Coroners name: Deborah Archer Coroners Area: Plymouth Torbay and South Devon Category: Hospital Death (Clinical Procedures and medical management) related deaths This report is being sent to: University